Arq, Inc. (ARQ) 8-K Current Report: March 3, 2026
Filed: March 3, 2026
Health Care
Miscellaneous Chemical ProductsArq, Inc. (ARQ) 8-K current report filed with SEC EDGAR on March 3, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.
Reported 8-K Items1 item
- Item 1.01: Entry into a Material Definitive Agreement
Arq, Inc. 8-K Mar 3, 2026 Event Analysis
Item 1.01 · Entry into a Material Definitive Agreement
- • Fourth amendment to revolving credit facility with MidCap Funding IV Trust, dated Feb 27, 2026 — fourth modification since Dec 2024 signals ongoing liquidity stress
- • Minimum liquidity covenant reduced to $2.0M (through Mar 31, 2026), stepping back up to $5.0M on Apr 1, 2026
- • Borrowing availability calculation also extended/relaxed, providing near-term flexibility to draw on the revolver
- • Frequency of amendments (4 in ~14 months) flags persistent covenant pressure — investors should monitor Q1 2026 liquidity closely ahead of the Apr 1 step-up
Other Arq, Inc. 8-K Filings
Get deeper insights on Arq, Inc.
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.